Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves

被引:0
|
作者
Okagawa, Tomohiro [1 ]
Konnai, Satoru [1 ,2 ,3 ]
Nakamura, Hayato [2 ]
Ganbaatar, Otgontuya [2 ]
Sajiki, Yamato [2 ]
Watari, Kei [2 ]
Noda, Haruka [4 ]
Honma, Mitsuru [4 ]
Kato, Yukinari [5 ,6 ]
Suzuki, Yasuhiko [1 ,3 ,7 ,8 ]
Maekawa, Naoya [1 ]
Murata, Shiro [1 ,2 ]
Ohashi, Kazuhiko [1 ,2 ,9 ]
机构
[1] Hokkaido Univ, Fac Vet Med, Dept Adv Pharmaceut, Sapporo 0600818, Japan
[2] Hokkaido Univ, Fac Vet Med, Dept Dis Control, Sapporo 0600818, Japan
[3] Hokkaido Univ, Inst Vaccine Res & Dev HU IVReD, Sapporo 0010021, Japan
[4] Snow Brand Seed Co Ltd, Hokkaido Res Stn, Naganuma 0691464, Japan
[5] Tohoku Univ, Dept Antibody Drug Dev, Grad Sch Med, Sendai 9808575, Japan
[6] Tohoku Univ, Dept Mol Pharmacol, Grad Sch Med, Sendai 9808575, Japan
[7] Hokkaido Univ, Int Inst Zoonosis Control, Div Bioresources, Sapporo 0010020, Japan
[8] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Sapporo 0010020, Japan
[9] Hokkaido Univ, Fac Vet Med, Int Affairs Off, Sapporo 0600818, Japan
关键词
PD-L1; PD-1; T cell; live attenuated vaccine; immunotherapy; cattle; RESPIRATORY SYNCYTIAL VIRUS; VIRAL-DIARRHEA-VIRUS; IMMUNE-RESPONSE; GAMMA-DELTA; INFECTION; ANTIBODY; IFN; IMMUNOLOGY; EXHAUSTION; CD4;
D O I
10.3390/vaccines11030559
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interactions between programmed death 1 (PD-1) and PD-ligand 1 (PD-L1) cause functional exhaustion of T cells by inducing inhibitory signals, thereby attenuating effector functions of T cells. We have developed an anti-bovine PD-L1 blocking antibody (Ab) and have demonstrated that blockade of the interaction between PD-1 and PD-L1 reactivates T-cell responses in cattle. In the present study, we examined the potential utility of PD-1/PD-L1-targeted immunotherapy in enhancing T-cell responses to vaccination. Calves were inoculated with a hexavalent live-attenuated viral vaccine against bovine respiratory infections in combination with treatment with an anti-PD-L1 Ab. The expression kinetics of PD-1 in T cells and T-cell responses to viral antigens were measured before and after vaccination to evaluate the adjuvant effect of anti-PD-L1 Ab. PD-1 expression was upregulated in vaccinated calves after the administration of a booster vaccination. The activation status of CD4(+), CD8(+), and gamma delta TCR+ T cells was enhanced by the combination of vaccination and PD-L1 blockade. In addition, IFN-gamma responses to viral antigens were increased following combinatorial vaccination with PD-L1 blockade. In conclusion, the blockade of the PD-1/PD-L1 interaction enhances T-cell responses induced by vaccination in cattle, indicating the potential utility of anti-PD-L1 Ab in improving the efficacy of current vaccination programs.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy
    Zuazo, Miren
    Arasanz, Hugo
    Fernandez-Hinojal, Gonzalo
    Jesus Garcia-Granda, Maria
    Gato, Maria
    Bocanegra, Ana
    Martinez, Maite
    Hernandez, Berta
    Teijeira, Lucia
    Morilla, Idoia
    Jose Lecumberri, Maria
    Fernandez de Lascoiti, Angela
    Vera, Ruth
    Kochan, Grazyna
    Escors, David
    EMBO MOLECULAR MEDICINE, 2019, 11 (07)
  • [32] Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity
    Verdura, Sara
    Cuyas, Elisabet
    Cortada, Eric
    Brunet, Joan
    Lopez-Bonet, Eugeni
    Martin-Castillo, Begona
    Bosch-Barrera, Joaquim
    Antonio Encinar, Jose
    Menendez, Javier A.
    AGING-US, 2020, 12 (01): : 8 - 34
  • [33] PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
    Bocanegra, Ana
    Blanco, Ester
    Fernandez-Hinojal, Gonzalo
    Arasanz, Hugo
    Chocarro, Luisa
    Zuazo, Miren
    Morente, Pilar
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 17
  • [34] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [35] High macrophage PD-L1 expression not responsible for T cell suppression
    Goldman, Naomi
    Lomakova, Yelizavet D.
    Londregan, Jennifer
    Bucknum, Amanda
    DePierri, Kelley
    Somerville, John
    Riggs, James E.
    CELLULAR IMMUNOLOGY, 2018, 324 : 50 - 58
  • [36] Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses
    Starke, Astrid
    Lindenmeyer, Maja T.
    Segerer, Stephan
    Neusser, Matthias A.
    Ruesi, Barbara
    Schmid, Daniel M.
    Cohen, Clemens D.
    Wuethrich, Rudolf P.
    Fehr, Thomas
    Waeckerle-Men, Ying
    KIDNEY INTERNATIONAL, 2010, 78 (01) : 38 - 47
  • [37] EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions
    Sasaki, Sho
    Nishikawa, Jun
    Sakai, Kohei
    Iizasa, Hisashi
    Yoshiyama, Hironori
    Yanagihara, Masashi
    Shuto, Takuya
    Shimokuri, Kanami
    Kanda, Teru
    Suehiro, Yutaka
    Yamasaki, Takahiro
    Sakaida, Isao
    GASTRIC CANCER, 2019, 22 (03) : 486 - 496
  • [38] PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression
    Tang, Haidong
    Liang, Yong
    Anders, Robert A.
    Taube, Janis M.
    Qiu, Xiangyan
    Mulgaonkar, Aditi
    Liu, Xin
    Harrington, Susan M.
    Guo, Jingya
    Xin, Yangchun
    Xiong, Yahong
    Nham, Kien
    Silvers, William
    Hao, Guiyang
    Sun, Xiankai
    Chen, Mingyi
    Hannan, Raquibul
    Qiao, Jian
    Dong, Haidong
    Peng, Hua
    Fu, Yang-Xin
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (02) : 580 - 588
  • [39] Targeting regulatory T cells in anti-PD-1/PD-L1 cancer immunotherapy
    Zhulai, Galina
    Oleinik, Eugenia
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2022, 95 (03)
  • [40] Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
    Huang, Kevin Chih-Yang
    Chiang, Shu-Fen
    Chen, William Tzu-Liang
    Chen, Tsung-Wei
    Hu, Ching-Han
    Yang, Pei-Chen
    Ke, Tao-Wei
    Chao, K. S. Clifford
    CANCERS, 2020, 12 (02)